GO
Loading...

Mad Mail: Google as a Long-Term Investment?

As he does from time to time, Cramer took your questions on Monday's Mad Money.

The first question came from John in Dallas, who asked for Cramer's thoughts on doubling down on Google or shifting to priceline.com for a long-term investment. Cramer does not want to own Google, which he said ceded China to BIDU. Priceline, however, is an overpriced stock.

In the next letter, Rev. Wilson asked if Gilead Sciences is worth holding onto, even thought it's taking a beating lately. A recent acquisition was too diluted, Cramer explained, and next year's earnings aren't supposed to be good.

Bob in Tolland, Conn. asked about Teva Pharmaceutical . I want to own the world's largest producer of generic drugs, said Cramer. Double-down on it.

Romanch in Buffalo, NY wondered about Cramer's recent recommendation of DreamWorks Animation , pointing out the stock has fallen 30%. Cramer said he got this call wrong and said it's now too low to sell.

The last letter came from John, who asked Cramer if he should own Manitowoc . Cramer recommends selling MTW in favor of CAT .

When this post was published, Cramer's charitable trust owned Teva Pharmaceutical.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
BIDU
---
CAT
---
DWA
---
GILD
---
MTW
---
PCLN
---
TEVA
---
GOOGL
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Cramer's New Book